Lung function abnormalities after bone marrow transplantation in children

Has the trend recently changed?

Isa Cerveri, Paola Fulgoni, Giovanna Giorgiani, Maria C. Zoia, Massimiliano Beccaria, Carmine Tinelli, Franco Locatelli

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Study objectives: To evaluate early and late lung function abnormalities and their predictors in a large sample of children who underwent bone marrow transplantation (BMT) for leukemias in the 1990s, highlighting changes with respect to the 1980s. Designs: Prospective cohort. Setting: A university department of pediatrics. Participants: Seventy-five consecutive children who underwent BMT were enrolled in the study (median age, 11 years; range, 6 to 19 years; 45 male and 30 female children). Twenty-three children received autologous BMT, and 52 children received allogeneic BMT; 50 children completed the study. Measurements: Clinical examinations and lung function tests were performed before BMT, and 3 to 6 months, 12 months, and 24 months after BMT. Results: Before BMT, at 3 to 6 months after BMT, and at 24 months after BMT, 44%, 85%, and 62% of children, respectively, had altered lung function in the absence of persistent respiratory symptoms. Between 3 months and 6 months after BMT, a restrictive pattern was the most frequent abnormality. The only predictive factors for late abnormalities were transplantation performed in the advanced disease phase (odds ratio [OR], 6.75; p = 0.005) and bronchopulmonary infections (OR, 3.9; p <0.05). Conclusions: These data suggest that a significant proportion of children who undergo BMT, especially if for leukemia in advanced phase, have early and late pulmonary abnormalities. These abnormalities, especially the late ones, seem to be more severe than patients reported in studies analyzing children undergoing BMT in the 1980s. This could be due to the more intensive front-line treatment protocols employed for treatment of children with acute leukemia in the 1990s.

Original languageEnglish
Pages (from-to)1900-1906
Number of pages7
JournalChest
Volume120
Issue number6
DOIs
Publication statusPublished - 2001

Fingerprint

Bone Marrow Transplantation
Lung
Leukemia
Odds Ratio
Autologous Transplantation
Respiratory Function Tests
Homologous Transplantation
Clinical Protocols
Transplantation
Pediatrics

Keywords

  • Bone marrow transplantation
  • Lung function

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Lung function abnormalities after bone marrow transplantation in children : Has the trend recently changed? / Cerveri, Isa; Fulgoni, Paola; Giorgiani, Giovanna; Zoia, Maria C.; Beccaria, Massimiliano; Tinelli, Carmine; Locatelli, Franco.

In: Chest, Vol. 120, No. 6, 2001, p. 1900-1906.

Research output: Contribution to journalArticle

@article{8c02997655274d2b99d4fb47d90a5a67,
title = "Lung function abnormalities after bone marrow transplantation in children: Has the trend recently changed?",
abstract = "Study objectives: To evaluate early and late lung function abnormalities and their predictors in a large sample of children who underwent bone marrow transplantation (BMT) for leukemias in the 1990s, highlighting changes with respect to the 1980s. Designs: Prospective cohort. Setting: A university department of pediatrics. Participants: Seventy-five consecutive children who underwent BMT were enrolled in the study (median age, 11 years; range, 6 to 19 years; 45 male and 30 female children). Twenty-three children received autologous BMT, and 52 children received allogeneic BMT; 50 children completed the study. Measurements: Clinical examinations and lung function tests were performed before BMT, and 3 to 6 months, 12 months, and 24 months after BMT. Results: Before BMT, at 3 to 6 months after BMT, and at 24 months after BMT, 44{\%}, 85{\%}, and 62{\%} of children, respectively, had altered lung function in the absence of persistent respiratory symptoms. Between 3 months and 6 months after BMT, a restrictive pattern was the most frequent abnormality. The only predictive factors for late abnormalities were transplantation performed in the advanced disease phase (odds ratio [OR], 6.75; p = 0.005) and bronchopulmonary infections (OR, 3.9; p <0.05). Conclusions: These data suggest that a significant proportion of children who undergo BMT, especially if for leukemia in advanced phase, have early and late pulmonary abnormalities. These abnormalities, especially the late ones, seem to be more severe than patients reported in studies analyzing children undergoing BMT in the 1980s. This could be due to the more intensive front-line treatment protocols employed for treatment of children with acute leukemia in the 1990s.",
keywords = "Bone marrow transplantation, Lung function",
author = "Isa Cerveri and Paola Fulgoni and Giovanna Giorgiani and Zoia, {Maria C.} and Massimiliano Beccaria and Carmine Tinelli and Franco Locatelli",
year = "2001",
doi = "10.1378/chest.120.6.1900",
language = "English",
volume = "120",
pages = "1900--1906",
journal = "Chest",
issn = "0012-3692",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Lung function abnormalities after bone marrow transplantation in children

T2 - Has the trend recently changed?

AU - Cerveri, Isa

AU - Fulgoni, Paola

AU - Giorgiani, Giovanna

AU - Zoia, Maria C.

AU - Beccaria, Massimiliano

AU - Tinelli, Carmine

AU - Locatelli, Franco

PY - 2001

Y1 - 2001

N2 - Study objectives: To evaluate early and late lung function abnormalities and their predictors in a large sample of children who underwent bone marrow transplantation (BMT) for leukemias in the 1990s, highlighting changes with respect to the 1980s. Designs: Prospective cohort. Setting: A university department of pediatrics. Participants: Seventy-five consecutive children who underwent BMT were enrolled in the study (median age, 11 years; range, 6 to 19 years; 45 male and 30 female children). Twenty-three children received autologous BMT, and 52 children received allogeneic BMT; 50 children completed the study. Measurements: Clinical examinations and lung function tests were performed before BMT, and 3 to 6 months, 12 months, and 24 months after BMT. Results: Before BMT, at 3 to 6 months after BMT, and at 24 months after BMT, 44%, 85%, and 62% of children, respectively, had altered lung function in the absence of persistent respiratory symptoms. Between 3 months and 6 months after BMT, a restrictive pattern was the most frequent abnormality. The only predictive factors for late abnormalities were transplantation performed in the advanced disease phase (odds ratio [OR], 6.75; p = 0.005) and bronchopulmonary infections (OR, 3.9; p <0.05). Conclusions: These data suggest that a significant proportion of children who undergo BMT, especially if for leukemia in advanced phase, have early and late pulmonary abnormalities. These abnormalities, especially the late ones, seem to be more severe than patients reported in studies analyzing children undergoing BMT in the 1980s. This could be due to the more intensive front-line treatment protocols employed for treatment of children with acute leukemia in the 1990s.

AB - Study objectives: To evaluate early and late lung function abnormalities and their predictors in a large sample of children who underwent bone marrow transplantation (BMT) for leukemias in the 1990s, highlighting changes with respect to the 1980s. Designs: Prospective cohort. Setting: A university department of pediatrics. Participants: Seventy-five consecutive children who underwent BMT were enrolled in the study (median age, 11 years; range, 6 to 19 years; 45 male and 30 female children). Twenty-three children received autologous BMT, and 52 children received allogeneic BMT; 50 children completed the study. Measurements: Clinical examinations and lung function tests were performed before BMT, and 3 to 6 months, 12 months, and 24 months after BMT. Results: Before BMT, at 3 to 6 months after BMT, and at 24 months after BMT, 44%, 85%, and 62% of children, respectively, had altered lung function in the absence of persistent respiratory symptoms. Between 3 months and 6 months after BMT, a restrictive pattern was the most frequent abnormality. The only predictive factors for late abnormalities were transplantation performed in the advanced disease phase (odds ratio [OR], 6.75; p = 0.005) and bronchopulmonary infections (OR, 3.9; p <0.05). Conclusions: These data suggest that a significant proportion of children who undergo BMT, especially if for leukemia in advanced phase, have early and late pulmonary abnormalities. These abnormalities, especially the late ones, seem to be more severe than patients reported in studies analyzing children undergoing BMT in the 1980s. This could be due to the more intensive front-line treatment protocols employed for treatment of children with acute leukemia in the 1990s.

KW - Bone marrow transplantation

KW - Lung function

UR - http://www.scopus.com/inward/record.url?scp=0035687916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035687916&partnerID=8YFLogxK

U2 - 10.1378/chest.120.6.1900

DO - 10.1378/chest.120.6.1900

M3 - Article

VL - 120

SP - 1900

EP - 1906

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -